SEngine Precision Medicine Company
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Early Drug Development
Investors Number:
5.0
Last Funding Date:
2022-07-28
Technology:
Biotechnology
Founded Date:
2015-01-01
Headquarters:
Seattle, Washington, United States
Total Funding:
21200000.0
Last Funding Type:
Series A
Employee Number:
11-50